Women Grow, which launched two years ago, has rapidly become one of the most powerful cannabis industry organizations, providing networking opportunities in 40 cities in North America on a...
Interview with Kerri Accardi, President of 420MEDIA Advertising is a huge challenge for companies in the cannabis industry, with television opportunities extremely rare. One activist and entrepreneur who is...
One of the most exciting themes in legalization is the progress being made in Canada, which is 28 months into its federal medical cannabis program, MMPR, and on the...
United Patients Group has been leading the way over the past few years as an unparalleled resource and trusted leader in the medical cannabis industry, helping patients, doctors and organizations become...
OrganiGram (TSXV:OGI) (OTC:OGRMF) soared 59% in April and is leading the Canadian LP YTD, with its stock up 29% through the end of April. Shareholder returns appears to be...
While Mettrum (TSXV:MT) is one of the leading licensed producers in Canada’s MMPR program, with revenue in its FY16-Q3 (December 2015) exceeding $2mm, the company has been relatively quiet over the...
Access to capital is critical for any industry. The state-legal cannabis industry struggles in this area for several reasons, including federal illegality, stigma issues that reduce the investor base,...
Supreme Pharma (CSE:SL) (OTCMKTS:SPRWF) received its license from Health Canada to begin cultivating cannabis on March 11th. Based in Kincardine, Ontario, the company owns a large hybrid greenhouse facility,...
Last week, Leafly, which bills itself as the “world’s largest cannabis information resource,” suddenly locked out developers in the cannabis industry from its application program interface (API). The API gave access...
Watch the webinar On January 7th, New Cannabis Ventures Founder Alan Brochstein hosted Troy Dayton, CEO of The ArcView Group, for a webinar to discuss the organization and how...
Empire State Health Solutions won one of just five MMJ licenses in New York. Check out this interview of its CEO, Dr. Kyle Kingsley, with 420 Investor’s Alan Brochstein
